Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People between the ages of 55 and 75 years old
- People who have given written consent to participate (or whose legal guardian has done so) before any study procedures begin
- People who have been diagnosed with Alzheimer's disease using established medical diagnostic guidelines (NIA-AA criteria), or who have been diagnosed with another form of dementia — such as Lewy body dementia, frontotemporal dementia (various types), Parkinson's disease dementia, vascular dementia, corticobasal degeneration, or Creutzfeldt-Jakob disease — each diagnosed using the relevant accepted medical criteria
- People with normal cognition, as confirmed through standard memory and thinking assessment tools (confirm with trial site for specific tests required)
Who may not be able to join:
- People who have another significant medical or psychiatric condition (confirm with trial site for specific details)
- People who do not have someone close to them (such as a family member or carer) who is able to provide information about them to the research team
- People who are not willing to complete cognitive (thinking and memory) tests or provide biological samples (such as blood or other specimens)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 8610-83199449
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The area under curve of the AD-seeds-detector for the accurate diagnosis of AD
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.